AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14649535 — intervention group
Group type: COMPARATOR
Intervention: Control (no education intervention)
Number of subjects: 62
Study 11118463 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX) 75 mg/m² and Cisplatin (CDDP) 100 mg/m² for six cycles at 3-week intervals; 232 (81%) received all six cycles.
Number of subjects: 287
Study 11118463 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX) and Cisplatin (CDDP) regimen with RDI less than 0.6.
Number of subjects: 287
Study 11118463 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin (DOX) and Cisplatin (CDDP) regimen.
Number of subjects: 287
Study 9104519 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl plus im ketorolac (Group A)
Number of subjects: 92
Study 9104519 — intervention group
Group type: COMPARATOR
Intervention: im ketorolac alone (Group P)
Number of subjects: 92
Study 8251720 — intervention group
Group type: EXPERIMENTAL
Intervention: Photosensitized Oxidation Auto‐Hemotherapy (POAH) with Buyang Huanwu Tang therapy
Number of subjects: 115
Study 8251720 — intervention group
Group type: COMPARATOR
Intervention: Photosensitized Oxidation Auto‐Hemotherapy (POAH) only
Number of subjects: 115
Study 8251720 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 115
Study 3513515 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg verapamil daily
Number of subjects: 24
Study 3513515 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg atenolol daily
Number of subjects: 24
Study 3513515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29298664 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-titrating continuous positive airway pressure (APAP) applied during sleep for 72 hours after surgery or until discharge if discharged before 72 hours.
Number of subjects: 634
Study 29298664 — intervention group
Group type: COMPARATOR
Intervention: Control group - routine care, no APAP.
Number of subjects: 634
Study 27809810 — intervention group
Group type: EXPERIMENTAL
Intervention: Directly mailed a second reminder including a HPV self-sampling kit
Number of subjects: 9327
Study 27809810 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed a second reminder offering a HPV self-sampling kit, to be ordered by e-mail, text message, phone, or through a webpage
Number of subjects: 9327
Study 27809810 — intervention group
Group type: COMPARATOR
Intervention: Mailed a second reminder for a practitioner-collected sample
Number of subjects: 9327
Study 27809810 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV self-collected sample
Number of subjects: 9327
Study 25411033 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended lentils (B)
Number of subjects: 12
Study 25411033 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole lentils (W)
Number of subjects: 12
Study 25411033 — intervention group
Group type: EXPERIMENTAL
Intervention: α-galactosidase
Number of subjects: 12
Study 25411033 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 12
Study 23184118 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrografin (3 mL/kg diluted 1:3 with water)
Number of subjects: 39
Study 23184118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 20484941 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus WBV (VIBRATION)
Number of subjects: 79
Study 20484941 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet only (DIET)
Number of subjects: 79
Study 20484941 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus fitness (FITNESS)
Number of subjects: 79
Study 20484941 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONTROL)
Number of subjects: 79
Study 18410889 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting energy expenditure (REE) in children and adolescents on hemodialysis
Number of subjects: 25
Study 18410889 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted resting energy expenditure (REE)
Number of subjects: 25
Study 18410889 — intervention group
Group type: EXPERIMENTAL
Intervention: Total energy expenditure (TEE)
Number of subjects: 25
Study 18410889 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status and growth deficit evaluation
Number of subjects: 25
Study 16821209 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA therapy (150 mg oral DHEA daily for 40 days)
Number of subjects: 30
Study 14581438 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate disodium (90 mg) administered intravenously every 3 weeks for 27 weeks
Number of subjects: 0
Study 14581438 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered every 3 weeks for 27 weeks
Number of subjects: 0
Study 14581438 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate disodium
Number of subjects: 0
Study 14581438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9826207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreas-kidney transplantation
Number of subjects: 31
Study 9826207 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondiabetic kidney transplantation
Number of subjects: 31
Study 9826207 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 31
Study 8728804 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological preparation (psychoprophylaxis)
Number of subjects: 60
Study 8728804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no psychological preparation)
Number of subjects: 60
Study 3137888 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegafur 400 mg/m2 and Tamoxifen 20 mg/daily (Group B)
Number of subjects: 554
Study 3137888 — intervention group
Group type: COMPARATOR
Intervention: Tegafur 400 mg/m2 alone (Group A)
Number of subjects: 554
Study 28741175 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment and management (GAM)
Number of subjects: 61
Study 28741175 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 28716108 — intervention group
Group type: EXPERIMENTAL
Intervention: Esoteric Connective Tissue Therapy (ECTT), 40 minutes per session, 4 weekly treatments
Number of subjects: 100
Study 28716108 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy, 50 minutes per session, 4 weekly treatments
Number of subjects: 100
Study 25703777 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisting Hand Assessment (AHA) and Jebsen‐Taylor Test of Hand Function (JTTHF) dominant upper limb score
Number of subjects: 101
Study 25703777 — intervention group
Group type: EXPERIMENTAL
Intervention: TVPS‐3 Visual Sequential Memory, TVPS‐3 Visual Closure, and JTTHF dominant upper limb score
Number of subjects: 101
Study 23811627 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80
Study 23811627 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 80
Study 21696071 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower uterine segment compression (LUSC) for 10 minutes
Number of subjects: 686
Study 21696071 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care with oxytocin, clamping and cutting umbilical cords, controlled cord traction, and uterine massage)
Number of subjects: 686
Study 21696071 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower uterine segment compression (LUSC)
Number of subjects: 686
Study 21696071 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 686
Study 19349308 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 123
Study 19349308 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive stress management
Number of subjects: 123
Study 19349308 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 123
Study 17132270 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol supplementation (400 IU RRR-alpha-tocopherol/day for 6 weeks)
Number of subjects: 0
Study 17132270 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol supplementation
Number of subjects: 0
Study 17132270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15595704 — intervention group
Group type: EXPERIMENTAL
Intervention: Grafted bone (iliac crest) used as onlay blocks, maxillary sinus inlay blocks, or in particulate form
Number of subjects: 40
Study 15595704 — intervention group
Group type: COMPARATOR
Intervention: Nongrafted bone
Number of subjects: 40
Study 15595704 — intervention group
Group type: EXPERIMENTAL
Intervention: Block grafts after 6 months
Number of subjects: 40
Study 11841196 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 5 mg/d
Number of subjects: 57
Study 11841196 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) 10 mg/d
Number of subjects: 57
Study 11841196 — intervention group
Group type: COMPARATOR
Intervention: 5-aminosalicylic acid (5-ASA) 1.6 g/d
Number of subjects: 57
Study 9150322 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (100 microg per nasal cavity b.i.d.)
Number of subjects: 42
Study 9150322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 7526028 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with ifosfamide, cisplatin, and adriamycin
Number of subjects: 94
Study 4073304 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured treatment (drug use exceeding set limits resulted in methadone withdrawal)
Number of subjects: 0
Study 4073304 — intervention group
Group type: COMPARATOR
Intervention: Unstructured treatment (no consequences attended continued drug use)
Number of subjects: 0
Study 31980691 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH-style diet intervention
Number of subjects: 19
Study 29291357 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert (MVI)
Number of subjects: 401
Study 29291357 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert (DVI)
Number of subjects: 401
Study 27471125 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide (HP) mouthwash 3%
Number of subjects: 68
Study 27471125 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) mouthwash 0.9%
Number of subjects: 68
Study 23319006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 369
Study 23319006 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral avoidance task
Number of subjects: 369
Study 23319006 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional neuroimaging during classical fear conditioning
Number of subjects: 369
Study 23319006 — intervention group
Group type: EXPERIMENTAL
Intervention: Differentiation in brain activation patterns post-CBT
Number of subjects: 369
Study 22071311 — intervention group
Group type: EXPERIMENTAL
Intervention: RT+ (irradiated group, n=30)
Number of subjects: 75
Study 22071311 — intervention group
Group type: COMPARATOR
Intervention: RT- (non-irradiated group, n=45)
Number of subjects: 75
Study 20929128 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetramethylpyrazine (TMP)
Number of subjects: 60
Study 20929128 — intervention group
Group type: COMPARATOR
Intervention: Low molecular dextran (Control)
Number of subjects: 60
Study 18620949 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon alfa‐2b 6 mug/kg per week for 8 weeks (induction) then 3 mug/kg per week (maintenance) for an intended duration of 5 years
Number of subjects: 1256
Study 18620949 — intervention group
Group type: COMPARATOR
Intervention: observation
Number of subjects: 1256
Study 18620949 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon alfa‐2b
Number of subjects: 1256
Study 17516971 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 micrograms self-administered vaginal misoprostol
Number of subjects: 0
Study 17516971 — intervention group
Group type: COMPARATOR
Intervention: Self-administered vaginal placebo
Number of subjects: 0
Study 15612099 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release methylphenidate tablets (18 mg to 54 mg/day in a single dose)
Number of subjects: 435
Study 15612099 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release methylphenidate capsules
Number of subjects: 435
Study 15612099 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release methylphenidate tablets
Number of subjects: 435
Study 15612099 — intervention group
Group type: COMPARATOR
Intervention: Short-acting methylphenidate
Number of subjects: 435
Study 10871573 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin A (60 mg retinol equivalent)
Number of subjects: 236
Study 10871573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 9181227 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy starting on postoperative day 1
Number of subjects: 163
Study 9181227 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy starting on postoperative day 7
Number of subjects: 163
Study 1327742 — intervention group
Group type: EXPERIMENTAL
Intervention: 55 g low-fibre oat bran
Number of subjects: 40
Study 1327742 — intervention group
Group type: EXPERIMENTAL
Intervention: 55 g high-fibre oat bran
Number of subjects: 40
Study 1327742 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 g mixed cooked beans
Number of subjects: 40
Study 1327742 — intervention group
Group type: COMPARATOR
Intervention: low-fat background diet (29% of energy from fat)
Number of subjects: 40
Study 3893961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg
Number of subjects: 50
Study 3893961 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 50 mg
Number of subjects: 50
Study 3893961 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg and Ranitidine 50 mg
Number of subjects: 50
Study 31140565 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZ)
Number of subjects: 140
Study 31140565 — intervention group
Group type: COMPARATOR
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 140
Study 24809656 — intervention group
Group type: EXPERIMENTAL
Intervention: Aussie current
Number of subjects: 21
Study 24809656 — intervention group
Group type: EXPERIMENTAL
Intervention: PC500 current
Number of subjects: 21
Study 24809656 — intervention group
Group type: EXPERIMENTAL
Intervention: PC200 current
Number of subjects: 21
Study 24809656 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian current
Number of subjects: 21
Study 24809656 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES combined with MVC
Number of subjects: 21
Study 24809656 — intervention group
Group type: COMPARATOR
Intervention: NMES
Number of subjects: 21
Study 23948023 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume-controlled ventilation (VVC)
Number of subjects: 26
Study 23948023 — intervention group
Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (VPC)
Number of subjects: 26
Study 21813065 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD163 at baseline (1.69mg/l (1.42‐2.10))
Number of subjects: 34
Study 21813065 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD163 at 9 months
Number of subjects: 34
Study 21813065 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline levels of sCD163
Number of subjects: 34
Study 21813065 — intervention group
Group type: EXPERIMENTAL
Intervention: sCD163 levels in RA patients
Number of subjects: 34
Study 19184245 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-CT
Number of subjects: 38
Study 19184245 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 38
Study 17163350 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Brain Self-Reference (dynBSR)
Number of subjects: 0
Study 12777644 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with ondansetron treatment
Number of subjects: 39
Study 12777644 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron treatment alone
Number of subjects: 39
Study 10836193 — intervention group
Group type: EXPERIMENTAL
Intervention: Fostimon
Number of subjects: 60
Study 10836193 — intervention group
Group type: COMPARATOR
Intervention: Metrodin HP
Number of subjects: 60
Study 9352450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA) treatment
Number of subjects: 9
Study 8462535 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapride
Number of subjects: 75
Study 8462535 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 75
Study 8462535 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 3884084 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan 0.2 mg/kg for 5 consecutive days every 6 weeks for 2 years
Number of subjects: 273
Study 3884084 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral combination therapy (melphalan 10 mg daily for 5 consecutive days, plus methotrexate 15 mg and 5-fluorouracil 250 mg on the first day, courses repeated every 6 weeks for 2 years)
Number of subjects: 273
Study 3884084 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant chemotherapy)
Number of subjects: 273
Study 30760314 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 108
Study 30760314 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 108
Study 30760314 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 108
Study 30336306 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning intervention where subjects selected the days and times they intended to attend the gym over the next two weeks
Number of subjects: 877
Study 30336306 — intervention group
Group type: COMPARATOR
Intervention: Control group who recorded their days of exercise in the prior two weeks
Number of subjects: 877
Study 27344833 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmar thumb surface group
Number of subjects: 60
Study 27344833 — intervention group
Group type: COMPARATOR
Intervention: Radial margin group
Number of subjects: 60
Study 24104592 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-Fluorocholine (FCH) PET/CT
Number of subjects: 23
Study 24104592 — intervention group
Group type: EXPERIMENTAL
Intervention: (11)C-Acetate (ACE) PET/CT
Number of subjects: 23
Study 22617413 — intervention group
Group type: EXPERIMENTAL
Intervention: Youth intervention
Number of subjects: 615
Study 22617413 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined youth and parent intervention
Number of subjects: 615
Study 22617413 — intervention group
Group type: COMPARATOR
Intervention: Intervention as usual (IAU)
Number of subjects: 615
Study 20562595 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg intravenous sotalol infusion administered over 2.5 hours
Number of subjects: 15
Study 20562595 — intervention group
Group type: COMPARATOR
Intervention: 80 mg oral sotalol
Number of subjects: 15
Study 20562595 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg intravenous sotalol administered as a 5-hour infusion
Number of subjects: 15
Study 20562595 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg intravenous sotalol administered over 5 hours
Number of subjects: 15
Study 17683529 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (RT)
Number of subjects: 3665
Study 17683529 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 3665
Study 16199676 — intervention group
Group type: EXPERIMENTAL
Intervention: Child care training session for fathers including management of breastfeeding
Number of subjects: 280
Study 16199676 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training session for fathers)
Number of subjects: 280
Study 16199676 — intervention group
Group type: EXPERIMENTAL
Intervention: Among women who reported difficulties with lactation
Number of subjects: 280
Study 12370871 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 hours of shaping training (6h/d group, n=7)
Number of subjects: 15
Study 12370871 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 hours of shaping training (3h/d group, n=8)
Number of subjects: 15
Study 9648994 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Escherichia coli 014
Number of subjects: 17
Study 9648994 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Proteus mirabilis
Number of subjects: 17
Study 9648994 — intervention group
Group type: EXPERIMENTAL
Intervention: Supernatant from live E. coli and P. mirabilis
Number of subjects: 17
Study 9648994 — intervention group
Group type: COMPARATOR
Intervention: Supernatants from bacteria treated with formaldehyde or glutaraldehyde
Number of subjects: 17
Study 9648994 — intervention group
Group type: COMPARATOR
Intervention: Other bacterial species (10 species tested)
Number of subjects: 17
Study 8122498 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (66 mg daily)
Number of subjects: 120
Study 8122498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 8122498 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 120
Study 2589359 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous followed by oral ciprofloxacin
Number of subjects: 122
Study 2589359 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin-gentamicin combination
Number of subjects: 122
Study 1099945 — intervention group
Group type: EXPERIMENTAL
Intervention: Ru-Tuss tablets
Number of subjects: 0
Study 1099945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31753712 — intervention group
Group type: EXPERIMENTAL
Intervention: In-vitro activation (IVA) procedure
Number of subjects: 11
Study 31610401 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Mediterranean dietary intervention
Number of subjects: 36
Study 31610401 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 36
Study 28577591 — intervention group
Group type: EXPERIMENTAL
Intervention: Factorial designs in clinical interventions
Number of subjects: 0
Study 25255169 — intervention group
Group type: EXPERIMENTAL
Intervention: Right rTMS (10 sessions at 10 Hz frequency; 20 trains per session; 4.9 seconds per train and intertrain interval 30 seconds)
Number of subjects: 20
Study 25255169 — intervention group
Group type: EXPERIMENTAL
Intervention: Left rTMS (10 sessions at 10 Hz frequency; 20 trains per session; 4.9 seconds per train and intertrain interval 30 seconds)
Number of subjects: 20
Study 25255169 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 20
Study 22739327 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (PLYO)
Number of subjects: 15